Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric carboxymaltose for iron deficiency in chronic heart failure
ACTRN12615000952549Phase 2Terminated
- Sponsor
- Professor Andrew Sindone
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ferric carboxymaltose in chronic heart failure (CHF) and iron deficiency anemia (IDA) (2 arms), sponsored by Professor Andrew Sindone. Primary endpoint: Change in Kansas City Cardiomyopathy Questionnaire score. Started Jul 2015; status: terminated.
02
Drugs
ferric carboxymaltose
03
Conditions
chronic heart failure (CHF)iron deficiency anemia (IDA)
Beyond the preview
Go deeper on ACTRN12615000952549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000952549.